In our in vivo study, we demonstrated that dual-targeted NBs that were dually targeted to both VEGFR2 and HER2 led to higher level of US imaging signals than either of the single-targeted NBs at sites of tumor angiogenesis or tumor cells in tumor-bearing mice. This evidence concerns the gene KDR and neoplasm.